319 related articles for article (PubMed ID: 31072659)
1. Helper-like innate lymphoid cells and cancer immunotherapy.
Crinier A; Vivier E; Bléry M
Semin Immunol; 2019 Feb; 41():101274. PubMed ID: 31072659
[TBL] [Abstract][Full Text] [Related]
2. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
Yuan X; Rasul F; Nashan B; Sun C
Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
[TBL] [Abstract][Full Text] [Related]
3. Helper innate lymphoid cells as cell therapy for cancer.
Magnusson FC; Bahhar I
Immunology; 2023 Apr; 168(4):569-579. PubMed ID: 36288454
[TBL] [Abstract][Full Text] [Related]
4. The role of helper innate lymphoid cells in cancer.
Hu S; Wang X
Immunotherapy; 2019 Aug; 11(12):1067-1081. PubMed ID: 31238781
[TBL] [Abstract][Full Text] [Related]
5. Hide and seek: Plasticity of innate lymphoid cells in cancer.
Bald T; Wagner M; Gao Y; Koyasu S; Smyth MJ
Semin Immunol; 2019 Feb; 41():101273. PubMed ID: 30979591
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells.
Munari E; Quatrini L; Ciancaglini C; Eccher A; Bogina G; Moretta L; Mariotti FR
Semin Immunol; 2022 Nov; 61-64():101660. PubMed ID: 36370672
[TBL] [Abstract][Full Text] [Related]
7. Progression or suppression: Two sides of the innate lymphoid cells in cancer.
Hosseini SH; Sharafkandi N; Seyfizadeh N; Hemmatzadeh M; Marofi F; Shomali N; Karimi M; Mohammadi H
J Cell Biochem; 2020 Apr; 121(4):2739-2755. PubMed ID: 31680296
[TBL] [Abstract][Full Text] [Related]
8. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
9. Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes.
Pesce S; Trabanelli S; Di Vito C; Greppi M; Obino V; Guolo F; Minetto P; Bozzo M; Calvi M; Zaghi E; Candiani S; Lemoli RM; Jandus C; Mavilio D; Marcenaro E
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255582
[TBL] [Abstract][Full Text] [Related]
10. Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
Tumino N; Vacca P; Quatrini L; Munari E; Moretta F; Pelosi A; Mariotti FR; Moretta L
Front Immunol; 2019; 10():3140. PubMed ID: 32063901
[TBL] [Abstract][Full Text] [Related]
11. Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy.
Ginefra P; Lorusso G; Vannini N
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580431
[TBL] [Abstract][Full Text] [Related]
12. The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy.
Sugimura R; Wang CY
Front Cell Dev Biol; 2022; 10():803563. PubMed ID: 35557940
[TBL] [Abstract][Full Text] [Related]
13. A distinct innate lymphoid cell population regulates tumor-associated T cells.
Crome SQ; Nguyen LT; Lopez-Verges S; Yang SY; Martin B; Yam JY; Johnson DJ; Nie J; Pniak M; Yen PH; Milea A; Sowamber R; Katz SR; Bernardini MQ; Clarke BA; Shaw PA; Lang PA; Berman HK; Pugh TJ; Lanier LL; Ohashi PS
Nat Med; 2017 Mar; 23(3):368-375. PubMed ID: 28165478
[TBL] [Abstract][Full Text] [Related]
14. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
15. Challenges and future perspectives of T cell immunotherapy in cancer.
de Aquino MT; Malhotra A; Mishra MK; Shanker A
Immunol Lett; 2015 Aug; 166(2):117-33. PubMed ID: 26096822
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-Mediated Regulation of Innate Lymphoid Cell Plasticity in Gut Mucosal Immunity.
De Salvo C; Buela KA; Pizarro TT
Front Immunol; 2020; 11():585319. PubMed ID: 33424837
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunity by tissue-resident type 1 innate lymphoid cells and killer innate-like T cells.
Zhang J; Li AM; Kansler ER; Li MO
Immunol Rev; 2024 May; 323(1):150-163. PubMed ID: 38506480
[TBL] [Abstract][Full Text] [Related]
19. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
20. Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells.
Ebihara T
Cells; 2020 May; 9(5):. PubMed ID: 32403291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
